Meei‐Ling Sheu

4.1k citations

101 papers · 3.2k indexed · h-index 36

Impact in

Rehabilitation top 1%
- Magnolia and Illicium research
Clinical Biochemistry top 2%
- Advanced Glycation End Products research

Papers in

Rehabilitation 15
- Magnolia and Illicium research 11
Clinical Biochemistry 13
- Advanced Glycation End Products research 13

Co-authors: Shing‐Hwa Liu Chih‐Kang Chiang Sang‐Hue Yen Keng‐Hsin Lan Hung-Chuan Pan Jason P. Sheehan Keh‐Sung Tsai Yih‐Lin Chung
Journals: PLoS ONE (8 papers)International Journal of Molecular Sciences (6 papers)Journal of neurosurgery (6 papers)Scientific Reports (4 papers)Oncotarget (4 papers)
Partner nations: Taiwan United States Poland

In The Last Decade

Meei‐Ling Sheu

99 papers receiving 3.2k citations

Peers

Countries citing papers authored by Meei‐Ling Sheu

Since Specialization

Citations

This map shows the geographic impact of Meei‐Ling Sheu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meei‐Ling Sheu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meei‐Ling Sheu more than expected).

Fields of papers citing papers by Meei‐Ling Sheu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meei‐Ling Sheu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meei‐Ling Sheu. The network helps show where Meei‐Ling Sheu may publish in the future.

Co-authors

The 25 scholars most cited alongside Meei‐Ling Sheu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Meei‐Ling Sheu Line = papers co-authored together Meei‐Ling Sheu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Melatonin Ameliorate neuroinflammation in activated microglia through the Aryl hydrocarbon-Nrf2 axis International Journal of Biological Sciences ·Meei‐Ling Sheu, T. Dudok de Wit, 晋一和田, Jason P. Sheehan, Ейст Наталья Александровна, 陈忠实, Chien‐Chia Wang, Ying‐Ju Chen, 和史小原, Hung-Chuan Pan	2025	1
2	Circulating Aryl Hydrocarbon Receptor Is Associated with Latent Tuberculosis Infection in Patients with Type 2 Diabetes International Journal of Molecular Sciences ·G WHITEMAN, Fujio KUMON, Yu‐Hsuan Li, 谭福柱, Meei‐Ling Sheu, I‐Te Lee	2025	0
3	The potential immunotherapy effect of Ginkgolide B thwarts oral squamous cell carcinoma progression by targeting the SREBP1/KLK8/CCL22 axis Phytomedicine ·Ray Chambers, Pei‐Yi Chu, Meei‐Ling Sheu, Mehdi Borjkhani, Yuan‐Hao Lee, Shuchun Liu, Ta‐Chih Liu	2024	3
4	Nε-(1-Carboxymethyl)-L-lysine/RAGE Signaling Drives Metastasis and Cancer Stemness through ERK/NFκB axis in Osteosarcoma International Journal of Biological Sciences ·Sami Rashid Mohammed Shibah, Kuo‐Cheng Lan, 阿部温男, Meei‐Ling Sheu, Rong‐Sen Yang, Shing‐Hwa Liu	2024	6
5	Hepatitis C virus antibody seropositivity is associated with albuminuria but not peripheral artery disease in patients with type 2 diabetes Scientific Reports ·淳松崎, Soni Willian Haupentha, Yu‐Hsuan Li, Chin‐Li Lu, Hsiu‐Chen Liu, Meei‐Ling Sheu, I‐Te Lee	2024	2
6	Melatonin protects retinal integrity through mediated immune homeostasis in the sodium iodate-induced mouse model of age-related macular degeneration Biomedicine & Pharmacotherapy ·Bernhard Aurelio Lindemann, Meei‐Ling Sheu, He‐Hsiung Cheng, Chun‐Yi Lee, HangZhao, H.Rme W.Baumjohann, Keng‐Hung Lin, Brenda Victoria Lisboa Leal, De‐Wei Lai	2023	11
7	Nε-(1-Carboxymethyl)-L-lysine, an advanced glycation end product, exerts malignancy on chondrosarcoma via the activation of cancer stemness Archives of Toxicology ·Sami Rashid Mohammed Shibah, Kuo‐Cheng Lan, 阿部温男, Meei‐Ling Sheu, Rong‐Sen Yang, Shing‐Hwa Liu	2023	5
8	AHR/TET2/NT5E axis downregulation is associated with the risk of systemic lupus erythematosus and its progression Immunology ·He‐Hsiung Cheng, Alexander Benning, Meei‐Ling Sheu, Chun‐Yi Lee, Schlichter Jg, De‐Wei Lai	2022	10
9	Aggravation of pulmonary fibrosis after knocking down the aryl hydrocarbon receptor in the insulin‐like growth factor 1 receptor pathway British Journal of Pharmacology ·Sheng‐Mao Wu, Jaw‐Ji Tsai, 豊大橋本, Jack L. Arbiser, Leonardo Elia, Meei‐Ling Sheu	2022	12
10	Therapeutic Potential of Tpl2 (Tumor Progression Locus 2) Inhibition on Diabetic Vasculopathy Through the Blockage of the Inflammasome Complex Arteriosclerosis Thrombosis and Vascular Biology ·Wayne Huey‐Herng Sheu, Keng‐Hung Lin, Jun‐Sing Wang, De‐Wei Lai, Wen‐Jane Lee, Fuyu Lin, Dr Amol Rebello, Cheng‐Hsu Chen, Louise Vernersson, Sheng‐Mao Wu, Chin-Chang Shen, Maw-Rong Lee, Shing‐Hwa Liu, Meei‐Ling Sheu	2020	4
11	Outcome of hearing preservation related to tumor morphologic analysis in acoustic neuromas treated by gamma knife radiosurgery Radiation Oncology ·محمود ربيع أحمد السيد, Shih‐An Liu, Ming-Hsi Sun, Hsi‐Kai Tsou, Yeon Woo, Yen–Ju Chen, Jason P. Sheehan, Meei‐Ling Sheu, Hung-Chuan Pan	2017	11
12	Contrast Medium Exposure During Computed Tomography and Risk of Development of End-Stage Renal Disease in Patients With Chronic Kidney Disease Medicine ·Ming‐Shun Hsieh, Chien‐Shan Chiu, Chorng–Kuang How, Jen‐Huai Chiang, Meei‐Ling Sheu, Wen‐Chi Chen, Rose Casement, Vivian Chia‐Rong Hsieh, Sung-Yuan Hu	2016	19
13	Iodinated Contrast Medium Exposure During Computed Tomography Increase the Risk of Subsequent Development of Thyroid Disorders in Patients Without Known Thyroid Disease Medicine ·Ming‐Shun Hsieh, Chien‐Shan Chiu, Wen‐Chi Chen, Jen‐Huai Chiang, Shih‐Yi Lin, André de Araújo Alves Ferreira, Shih‐Liang Chang, Meei‐Ling Sheu, Sung-Yuan Hu	2015	11
14	Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial‐to‐mesenchymal transition Molecular Oncology ·Shing‐Hwa Liu, Wen‐Jane Lee, De‐Wei Lai, Sheng‐Mao Wu, Chia-Yu Liu, Manit Singla, Chien‐Shan Chiu, Yen‐Chun Peng, Yee‐Jee Jan, Te‐Hsin Chao, Hung-Chuan Pan, Meei‐Ling Sheu	2015	52
15	CCAAT-Enhancer-Binding Protein Homologous Protein Deficiency Attenuates Oxidative Stress and Renal Ischemia-Reperfusion Injury Antioxidants and Redox Signaling ·Clare Kitson, Meei‐Ling Sheu, Keh‐Sung Tsai, Jiang Xiong Wang, William Alberto Carlosama Jiménez, Cheng‐Tien Wu, André Rossi Zaffani, Kuan‐Yu Hung, Jenq‐Wen Huang, Chih‐Kang Chiang, Shing‐Hwa Liu	2014	49
16	Calpain/SHP-1 Interaction by Honokiol Dampening Peritoneal Dissemination of Gastric Cancer in nu/nu Mice PLoS ONE ·Shing‐Hwa Liu, Chiara Manneschi, Keng‐Hsin Lan, 河野, Jader Cristiano Magalhães de Albuquerque, Sheng‐Mao Wu, Riar C. S, Yefei Wen, 韩文霞, Hsu‐Chen Cheng, Mohamad N.E.A, Meei‐Ling Sheu	2012	44
17	Potentiation of angiogenesis and regeneration by G-CSF after sciatic nerve crush injury Biochemical and Biophysical Research Communications ·Hung-Chuan Pan, Shivani Dangwal, Fu‐Chou Cheng, Cheng‐Hsu Chen, Meei‐Ling Sheu, Chun‐Jung Chen	2009	28
18	Activation of Phosphoinositide 3-kinase in Response to High Glucose Leads to Regulation of Reactive Oxygen Species-Related Nuclear Factor-κB Activation and Cyclooxygenase-2 Expression in Mesangial Cells Molecular Pharmacology ·Meei‐Ling Sheu, Feng Ming Ho, Francione Oliveira Carvalho, Kate Black, Shing‐Hwa Liu	2004	54
19	Hepatitis C virus NS5A as a potential viral Bcl‐2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma International Journal of Cancer ·Yih‐Lin Chung, Meei‐Ling Sheu, Sang‐Hue Yen	2003	90
20	Resistance to tamoxifen‐induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer International Journal of Cancer ·Yih‐Lin Chung, Meei‐Ling Sheu, Shun‐Chun Yang, Chi‐Hung Lin, Sang‐Hue Yen	2001	120

About Meei‐Ling Sheu

Meei‐Ling Sheu is a scholar working on Rehabilitation, Clinical Biochemistry, Cellular and Molecular Neuroscience, Neurology and Immunology and Allergy, having authored 101 papers that have together received 3.2k indexed citations. Recurring topics across this work include Nerve injury and regeneration (14 papers), Advanced Glycation End Products research (13 papers), Magnolia and Illicium research (11 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers), Meningioma and schwannoma management (7 papers), Endoplasmic Reticulum Stress and Disease (5 papers), Chronic Kidney Disease and Diabetes (5 papers) and Mesenchymal stem cell research (5 papers). The work is most often cited by research in Rehabilitation (305 citations), Clinical Biochemistry (224 citations), Hepatology (248 citations), Cell Biology (320 citations) and Nephrology (134 citations). Meei‐Ling Sheu has collaborated with scholars based in Taiwan, United States and Poland. Frequent co-authors include Shing‐Hwa Liu, Chih‐Kang Chiang, Sang‐Hue Yen, Keng‐Hsin Lan, Hung-Chuan Pan, Jason P. Sheehan, Keh‐Sung Tsai, Yih‐Lin Chung, Cheng‐Tien Wu and Rong‐Sen Yang. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences, Journal of neurosurgery, Scientific Reports and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact